Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 205

Similar articles for PubMed (Select 8195451)

1.
3.

Double-blind clonazepam vs placebo in panic disorder treatment.

Valença AM, Nardi AE, Nascimento I, Mezzasalma MA, Lopes FL, Zin W.

Arq Neuropsiquiatr. 2000 Dec;58(4):1025-9.

4.

Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder.

Ballenger JC, Wheadon DE, Steiner M, Bushnell W, Gergel IP.

Am J Psychiatry. 1998 Jan;155(1):36-42.

PMID:
9433336
5.

A controlled, prospective, 1-year trial of citalopram in the treatment of panic disorder.

Lepola UM, Wade AG, Leinonen EV, Koponen HJ, Frazer J, Sjödin I, Penttinen JT, Pedersen T, Lehto HJ.

J Clin Psychiatry. 1998 Oct;59(10):528-34.

PMID:
9818634
6.

Early coadministration of clonazepam with sertraline for panic disorder.

Goddard AW, Brouette T, Almai A, Jetty P, Woods SW, Charney D.

Arch Gen Psychiatry. 2001 Jul;58(7):681-6.

PMID:
11448376
7.

A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.

Pollack MH, Lepola U, Koponen H, Simon NM, Worthington JJ, Emilien G, Tzanis E, Salinas E, Whitaker T, Gao B.

Depress Anxiety. 2007;24(1):1-14.

PMID:
16894619
8.

Sertraline in the treatment of panic disorder: a double-blind multicenter trial.

Pohl RB, Wolkow RM, Clary CM.

Am J Psychiatry. 1998 Sep;155(9):1189-95.

PMID:
9734541
10.

Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial.

Stahl SM, Gergel I, Li D.

J Clin Psychiatry. 2003 Nov;64(11):1322-7.

PMID:
14658946
11.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Epub 2008 Aug 15. Review. French.

PMID:
18922243
12.

Double-blind acute clonazepam vs. placebo in carbon dioxide-induced panic attacks.

Nardi AE, Valença AM, Nascimento I, Mezzasalma MA, Zin WA.

Psychiatry Res. 2000 May 15;94(2):179-84.

PMID:
10808043
13.

Sertraline treatment of panic disorder: response in patients at risk for poor outcome.

Pollack MH, Rapaport MH, Clary CM, Mardekian J, Wolkow R.

J Clin Psychiatry. 2000 Dec;61(12):922-7.

PMID:
11206597
14.

A double-blind placebo-controlled trial comparing fluvoxamine and imipramine in the treatment of panic disorder with or without agoraphobia.

Bakish D, Hooper CL, Filteau MJ, Charbonneau Y, Fraser G, West DL, Thibaudeau C, Raine D.

Psychopharmacol Bull. 1996;32(1):135-41.

PMID:
8927663
15.

Psychopharmacotherapy of panic disorder: 8-week randomized trial with clonazepam and paroxetine.

Nardi AE, Valença AM, Freire RC, Mochcovitch MD, Amrein R, Sardinha A, Levitan MN, Nascimento I, de-Melo-Neto VL, King AL, de O E Silva AC, Veras AB, Dias GP, Soares-Filho GL, da Costa RT, Mezzasalma MA, de Carvalho MR, de Cerqueira AC, Hallak JE, Crippa JA, Versiani M.

Braz J Med Biol Res. 2011 Apr;44(4):366-73. Epub 2011 Feb 18.

16.

Pindolol augmentation in patients with treatment-resistant panic disorder: A double-blind, placebo-controlled trial.

Hirschmann S, Dannon PN, Iancu I, Dolberg OT, Zohar J, Grunhaus L.

J Clin Psychopharmacol. 2000 Oct;20(5):556-9.

PMID:
11001241
18.

Efficacy and tolerability of controlled-release paroxetine in the treatment of panic disorder.

Sheehan DV, Burnham DB, Iyengar MK, Perera P; Paxil CR Panic Disorder Study Group.

J Clin Psychiatry. 2005 Jan;66(1):34-40.

PMID:
15669886
19.

Alprazolam plasma concentrations and treatment response in panic disorder and agoraphobia.

Lesser IM, Lydiard RB, Antal E, Rubin RT, Ballenger JC, DuPont R.

Am J Psychiatry. 1992 Nov;149(11):1556-62.

PMID:
1415824
20.

Clonazepam treatment of panic disorder in patients with recurrent chest pain and normal coronary arteries.

Wulsin LR, Maddock R, Beitman B, Dawaher R, Wells VE.

Int J Psychiatry Med. 1999;29(1):97-105.

PMID:
10376236
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk